News
extended half-life factor VIII concentrate, for use in pediatric patients 7 years of age and older with hemophilia A (congenital Factor VIII deficiency). The approval is based on data from the ...
Robust CAR T-cell expansion was detected across all dose levels. At 3 months after infusion, a complete or partial response was seen in 81% of the patients (90% confidence interval [CI], 62 to 93 ...
He was treated with 40 mg methylprednisolone sodium succinate in a physiologic salt 100 mg intravenous drip and 1 g vitamin C in a 500 mL intravenous drip of glucose. Laboratory tests revealed ...
(Runner-up: the intravenous drip used to rehydrate participants.) It all makes for golden late-night-comedy fodder and, sure, it offends our collective prim-and-proper sensibilities. But there’s ...
Add articles to your saved list and come back to them any time. Nine is planning a swoop on the Formula 1 broadcast rights for its Stan Sport platform, with home-grown star Oscar Piastri’s ...
U.S. FDA Grants Approval for Jivi® Antihemophilic Factor (Recombinant), PEGylated-aucl in Pediatric Patients 7 to Under 12 Years of Age With Hemophilia A (Congenital Factor VIII Deficiency ...
This patient was treated with a single dose of PM359, administered by intravenous infusion. NADPH oxidase activity was measured by the dihydrorhodamine (DHR) assay at baseline, Day 15 and Day 30.
The dosage schedule varied from eight hourly injections to a constant intravenous drip. When heparin was given intermittently, the outer surface of the rubber cap was cleansed with isopropyl ...
He had been on a drip due to a leg infection. “I made the call with the club to go to hospital and go on the IV and I didn’t really take to the IVs too well,” Farnworth said the day after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results